Legal And Operational Duties Of The QP Flashcards
What are the operational duties of the QP
Manufacture and testing sites are consist with the MA
Manufacture and testing and certification completed as per MA
Source and specification of starting materials are as per MA and supplier management for control and supply in place
TSE status as per MA, where applicable
Finished product testing is completed in line with the specification listed in the MA
Audits of manufacturing and testing sites are completed and available to the QP
Self inspection schedule is active and current
Required technical agreements in place
Supply chain for the manufacturing train from API starting material through to release is known and available to the QP
Processes and testing remain in a validated state and personnel are trained and qualified
API is manufactured to GMP and distributed to GDP
Written confirmation of any API imported from a third country is available
Agreement for distribution are in place
Excipients manufactured to appropriate level of GMP
Safety features affixed to packaging
Manufacture and testing to GMP
Records are complete and endorsed by appropriate personnel, IPC checks complete
Any investigations completed to a level that does not negate certification
Changes assessed and any additional action complete
Complaints, investigations, recalls investigations do not negate release
Post market commitments completed and stability supports ongoing release
Legal duties of a commercial QP
As per human medicine regulation 2012/1916 schedule 7 the QP must personally ensure a number of duties have been completed prior to release for sale:
Each batch of medicinal product inks manufactured to GMP, the marketing authorisation and any local and National legislation
Any imports from a third country should undergo full qualitative and quantitative analysis of at least the active substances
Any batch manufactured for import into the EU should have appropriate safety features affixed to the packaging
Each batch certified in a register
Legal duties of an IMP QP
As per statutory instrument 2004/1031 part 6 the QP should personally ensure a number of duties are complete before a batch can be release for clinical evaluation:
Each batch manufactured to GMP, the CTA and the PSF
Each batch has been tested and complies to the specification detailed in the psf
Any batch (including comparators) sourced from a third country has been manufactured to GMP
Each batch certified in a register